← Leaderboards
Carolina Luisa Haass-Koffler
Brown University
$5,400,151
Attributed
$5,400,151
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $963.2K · FY2016–25$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,400,151 · 6
By mechanism
R01$3,355,668 · 2
K01$901,413 · 1
R34$474,481 · 1
R21$426,563 · 1
P20$242,026 · 1
Top collaborators
No co-investigators on record.
Most similar at Brown University
Same institution · by research overlap
- Christopher W. Kahler$25,030,333
- Kimberly Goodyear$842,182
- George Karniadakis$6,018,310
- William Nardi$143,420
- George Anthony Kenna$2,623,960
Others in their field
Top investigators on “Placebos”
- Beth Baseler · Leidos Biomedical Research, Inc.$141,816,521
- Randall J Bateman · Washington University$134,290,222
- Elizabeth A Thom · George Washington University$115,751,620
- Eric Martin McDade · Washington University$96,859,497
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$93,253,804
- Georgia D Tomaras · Fred Hutchinson Cancer Center$93,253,804
Research focus
PlacebosLaboratoriesPharmaceutical PreparationsAlcohol CravingAlcohol Use DisorderAlcohol ConsumptionAlcoholsPharmacotherapyCravingFutureCue ReactivityCommunitiesCuesStressDoseResponseAlcohol DependenceDrug Response PredictionDouble-Blind MethodDrinkingPharmacological TreatmentBiological MarkersAcuteAnimal Model
Grant awards (18)
Probenecid for Alcohol Use Disorder$733,137
R01 · FY2025 · AA · contact PI
Intranasal Insulin Administration as Medication for Alcohol Use Disorder$230,088
R34 · FY2025 · AA · contact PI
Intranasal Insulin Administration as Medication for Alcohol Use Disorder$244,393
R34 · FY2024 · AA · contact PI
A focus on alpha-1 blockade as a novel pharmacological treatment for alcohol use disorder$447,961
R01 · FY2023 · AA · contact PI
A focus on alpha-1 blockade as a novel pharmacological treatment for alcohol use disorder$514,069
R01 · FY2022 · AA · contact PI
A focus on alpha-1 blockade as a novel pharmacological treatment for alcohol use disorder$80,875
R01 · FY2022 · AA · contact PI
A focus on alpha-1 blockade as a novel pharmacological treatment for alcohol use disorder$509,459
R01 · FY2021 · AA · contact PI
Probenecid as pharmacotherapy for alcohol use disorder$192,969
R21 · FY2021 · AA · contact PI
A focus on alpha-1 blockade as a novel pharmacological treatment for alcohol use disorder$80,992
R01 · FY2021 · AA · contact PI
A focus on alpha-1 blockade as a novel pharmacological treatment for alcohol use disorder$509,243
R01 · FY2020 · AA · contact PI
Probenecid as pharmacotherapy for alcohol use disorder$233,594
R21 · FY2020 · AA · contact PI
Mifepristone As A Pharmacological Intervention For Stress-Induced Alcohol Drinking$180,481
K01 · FY2020 · AA · contact PI
A focus on alpha-1 blockade as a novel pharmacological treatment for alcohol use disorder$479,932
R01 · FY2019 · AA · contact PI
Oxytocin to reduce stress-induced craving in patients with opioid use disorder.$242,026
P20 · FY2019 · GM · contact PI
Mifepristone As A Pharmacological Intervention For Stress-Induced Alcohol Drinking$180,481
K01 · FY2019 · AA · contact PI
Mifepristone As A Pharmacological Intervention For Stress-Induced Alcohol Drinking$180,481
K01 · FY2018 · AA · contact PI
Mifepristone As A Pharmacological Intervention For Stress-Induced Alcohol Drinking$179,974
K01 · FY2017 · AA · contact PI
Mifepristone As A Pharmacological Intervention For Stress-Induced Alcohol Drinking$179,996
K01 · FY2016 · AA · contact PI